CohBar
Menlo Park
About CohBar
CohBar is a clinical-stage biotechnology company that focuses on the research and development of mitochondria based therapeutics. It has developed proprietary mitochondria based therapeutic (MBT) platform technology, using cell-based assays and animal models of disease, to rapidly identify naturally occurring MDPs with promising biological activity. The company was founded in 2007 and is headquartered in Menlo Park, California.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Public
- Employees: 1 – 10
- Estimated revenue: Less than $1M
- Total funding: $39.5M
- Funding stage: IPO
- Last round: Post-IPO Equity (Oct 2021)
- Ticker: nasdaq:CWBR
- Website: cohbar.com
- Phone: 4153818980
Industries & Categories
Biotechnology, Developer Platform, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/cohbar-179059 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.